What You Should Know:
– Lunit, an innovator in AI-powered cancer diagnostics, and Samsung Electronics (Samsung Healthcare) have announced a groundbreaking three-year supply contract.
– The strategic partnership integrates Lunit’s cutting-edge AI technology into Samsung’s premium…
Continue Reading
Bering Limited’s achievement of FDA clearance for BraveCX, an AI-powered chest X-ray triage tool, represents a significant breakthrough in the field of medical technology. This milestone not only underscores the company’s commitment to innovation…
Continue Reading
A digital health collaboration is to evaluate the use of AI in chest x-rays in Glasgow, with the Scottish government, University of Glasgow, Qure.ai and NHS Greater Glasgow and Clyde jointly working to assess…
Continue Reading
By Shania Kennedy
December 05, 2023 – A deep learning model can accurately identify non-smokers at high risk for lung cancer using only routine chest X-rays, according to research presented at this year’s meeting of the…
Continue Reading
AI’s prowess predicts lung cancer risk in non-smokers through routine chest X-rays. The study unveils an advanced “CXR-Lung-Risk” model, identifying 28% of participants at significantly higher risk. Dr. Lu emphasizes its pivotal role amid…
Continue Reading
Annalise.ai introduces Annalise Triage in the US, an innovative radiology triage software aiding in the swift diagnosis of critical conditions. It features AI-enhanced worklist triaging and 12 FDA-cleared findings for chest X-rays and head…
Continue Reading
What You Should Know:
– Annalise.ai, a global leader in the radiology imaging sector, announced the launch of Annalise Triage, an AI-powered worklist solution for chest X-rays and head CTs tailored specifically for the U.S….
Continue Reading
DeepTek.ai has achieved FDA clearance for its pioneering Chest X-ray AI solution, the CXR Analyzer, marking a significant milestone. This advanced technology employs deep learning algorithms to automatically detect and categorize abnormalities in chest…
Continue Reading
The LungIMPACT trial – a collaborative study between UK academia, NHS hospitals and Qure.ai is now gathering real-world evidence of AI-assisted diagnosis of lung cancer.Using Qure.ai’s gXR solution, the LungIMPACT trial is triaging chest…
Continue Reading
In a study of 2,000 chest X-rays, radiologists proved more accurate than AI in detecting common lung diseases. AI achieved sensitivity rates similar to radiologists but produced more false positives, especially in complex cases….
Continue Reading
